Commercial Rival Cannot Appeal Grant of Insecticide Registration, Rules Supreme Court

The Supreme Court has ruled that a commercial rival cannot appeal the grant of an insecticide registration under the Insecticides Act, 1968. Such a competitor, the Court said, is not an aggrieved person for Section 10. A bench of Justice M.M. Sundresh and Justice Prasanna B. Varale passed the order on October 14, 2026, in SLP (C) No. 22380 of 2026. It set aside the Delhi High Court order that had quashed the registration certificate granted to Crystal Crop Protection Ltd for Halosulfuron methyl at the instance of Dhanuka Agritech Ltd, and restored the certificate.

The question was a short one. Who can invoke the statutory appeal, and against what order? The bench said Section 10 does not create an open right to object to a registration granted to another company. It gives an appeal only to a person hit by refusal of registration or cancellation of a registration already granted. A grant to one applicant, the Court reasoned, does not by itself cause a market rival a legal injury the statute recognises.

Crystal Crop Protection had secured registration for Halosulfuron methyl. Dhanuka Agritech, a competitor in the same product segment, questioned the registration. The Delhi High Court accepted the challenge and quashed the certificate. Crystal Crop Protection then sought leave to appeal. The Supreme Court granted leave and, after hearing the parties, allowed the appeal.

Appeal Limits Under Insecticides Act, 1968

Section 10 deals with appeals against decisions of the registration authority. The Court read the text closely. It said the language speaks of a person aggrieved by refusal to register or by cancellation of registration. Those words, the bench said, point to the applicant denied registration, or the holder whose registration was cancelled. They do not point to a third party selling a competing product and fearing loss of business. Loss of that kind is a commercial consequence, not a legal wrong under the registration scheme.

An appeal is not the same as a writ petition raising a general grievance. It is a remedy created by the statute, and only those to whom the statute gives it can use it. The High Court, the Supreme Court said, had erred in treating a rival as entitled to invoke that remedy to attack a grant. Once the Court took that view on maintainability, the challenge to Crystal Crop Protection's certificate could not stand. The quashing order had to go.

The Court did not enter the merits of whether Halosulfuron methyl met the technical requirements for registration. Its order turned on standing. By restoring the certificate, the bench put the registration back where it was before the High Court's interference. For Crystal Crop Protection, the effect is that it can rely on the certificate subject to the conditions of grant and to any action the authorities may lawfully take in future under the Act and the rules.

Delhi High Court Order Set Aside

The High Court had quashed the registration at Dhanuka Agritech's instance. That order now stands set aside. In practical terms, its findings against the registration do not survive. The registration authority's decision to grant the certificate stands revived. The Supreme Court ordered no fresh grant. It simply removed the judicial order that had nullified the existing grant.

For Dhanuka Agritech, the outcome is that its objection to a rival's product could not be pursued through a Section 10 appeal. The judgment does not say a company has no remedy if a registration is obtained by fraud or in breach of mandatory procedure. It says the competitor cannot present itself as an aggrieved person under that section to appeal a grant. Any other challenge would have to rest on a different legal basis and satisfy the tests for that remedy, including locus and proof of legal injury.

The agro-chemical market in India is closely contested, with several firms seeking registration for similar molecules and formulations. Registrations decide who can make and sell a product, and fights between rivals over approvals are not uncommon. The ruling draws a line around such disputes. It stops a company from using the appeal route to delay or block a competitor's entry after the regulator has cleared the product. It leaves the regulator free to test safety, efficacy and quality at the time of grant, and to cancel a certificate later if the grounds for cancellation are made out.